ABOUT BYTERNA

An AI-Native RNA therapeutics company focused on programmable immunity.

Two membrane rings surround a centered square chip with faint circuit traces and changing binary digits. In the foreground, the sequences A, T, G, C and A, U, G, C are typed with a cursor. The chip responds subtly to each input. Byte represents computational intelligence. Byte plus RNA equals Byterna. The rings rotate into the official Byterna logo. Decoding life. Coding tomorrow’s cures.

Two alphabets of life.
One name: Byterna.

DNA’s A, T, G and C, and RNA’s A, U, G and C, are the alphabets through which life stores, expresses and regulates genetic information.

In our name, byte represents the computational intelligence to understand and design with biological information. RNA grounds that ambition in the development of new therapeutics.

Together, they express our AI-native approach: connecting computation, biological design and experimental learning to pursue meaningful advances for patients.

Byterna Therapeutics is an AI-native platform company focused on in vivo RNA therapeutics. We integrate artificial intelligence, RNA biology and experimental research to advance programmable immunity through innovative RNA medicines. Our R&D is supported by byterna.AI, our agentic AI operating system, with NeoDiscovery.AI dedicated to personalized cancer vaccine development. Our programs span in vivo CAR-T therapies and personalized mRNA cancer vaccines, with a focus on unmet medical needs in oncology and autoimmune diseases.

Vision

A future where programmable immunity brings precision medicine to more patients.

Mission

To unite artificial intelligence and life science to develop innovative therapies for serious diseases and deliver meaningful value to patients.

03 · PRIDE

Values

PPatients First
RRigor & Integrity
IIntelligent Innovation
DDiverse Collaboration
EExcellence in Execution